About Advarra
Advarra is #1 in trusted clinical research review services, #1 in innovative site and sponsor technology, and the pioneer in clinical research experience software. Our unique portfolio of technology and services decreases technology burden, improves study visibility, and enables smarter decisions to advance clinical research.
Our breadth of technology and depth of people expertise combine to deliver solutions to enable the collaboration, transparency, and speed required to optimize trial operations, ensure patient safety and engagement, and transform clinical research.
Headquartered in Columbia, Maryland, Advarra’s extensive geographic reach helps clients navigate the evolving research and regulatory environment.


Our Core Values

Who We Serve

3,500
institutions, hospitals, health systems, and academic medical centers
4,000+
pharma and CROs (including seven of the top 10 pharma and four of the top five CROs)
50K+
investigators
12K+
open protocols
88%
of NCI-Designated Cancer Centers
Diversity, Equity, and Inclusion (DE&I)
We believe in fostering a work environment where employees feel comfortable in bringing their authentic selves to work, irrespective of any personal characteristics including, but not limited to, race, ethnicity, religion, sex, gender identity, sexual orientation, national origin, age, veteran status, or disability (physical or mental). We value diversity in every form and strive for all Advarra team members to have a voice, experience a sense of belonging, and feel valued and respected.
In addition, we believe addressing underrepresented populations in clinical trials is a shared responsibility, requiring a multi-pronged effort across the industry. We consistently seek meaningful ways to assist our clients in solving the challenge of increasing participation of underrepresented populations in clinical trials through our products and services. We also regularly partner with thought leaders in the industry to focus on critical issues in DE&I within clinical research, as well as ideate possible solutions.
In addition, we believe addressing underrepresented populations in clinical trials is a shared responsibility, requiring a multi-pronged effort across the industry. We consistently seek meaningful ways to assist our clients in solving the challenge of increasing participation of underrepresented populations in clinical trials through our products and services. We also regularly partner with thought leaders in the industry to focus on critical issues in DE&I within clinical research, as well as ideate possible solutions.


Are You Ready for a Better, Faster Trial Experience?
Subscribe to our monthly email
Receive updates monthly about webinars for CEUs, white papers, podcasts, and more.
